维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Oshlack"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Characterization and validation of a pharmacokinetic model for con- trolled-release oxycodone 显示文摘	Mandema JW Kaiko RF Oshlack B	1996	Br J Clin Pharmacol1996，42，6：	1
2	Characterization and validation of a pharmacokinetic model for controlled-release oxycodone显示文摘	Mandema JW Kaiko RF Oshlack B	1996	Br J Clin Pharmacol1996，42，6：	1
3	Characterization and validation of a pharmacokinetic model for controlled-release oxycodone显示文摘	Madema JW Kaiko RF Oshlack B	1996	Br J Clin Pharmocol1996，42，6：	1
4	Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis显示文摘	Berkovic SF Dibbens LM Oshlack A	2008	Am J Hum Genet2008，82，3：	1
5	Characterization and validation of a pharmacokinetic model for controlled-release oxycodone显示文摘	Mandema J W Kaiko R F Oshlack B	1996	Br J Clin Pharmacol1996，42，6：	1
6	Characterization and validation of a pharmacokinetic model for controlled re- lease oxycodone显示文摘	Mandema JW Kaiko RF Oshlack B	1996	Br J Clin Pharmol1996，42，6：	1
7	Characterization and validation of a pharmacokinetic model for controlled-release oxycodone显示文摘	Mandema JW Kaiko RF Oshlack B ct al	1996	BrJ Clin Pharmacol1996，42，6：	1
8	SWAN:Subset-quantilewithin array normalization for illumina inflnium HumanMethyla-tion450 BeadChips显示文摘	Maksimovic J Gordon L Oshlack A	2012	Genome Biol2012，13，6：	1
9	Steady - state bioavailability of controlledrelease oxycodone in normal subjects显示文摘	Reder R F Oshlack B Miotto J B	1996	Clin Ther1996，18，：	1
10	Characterization and validation of a pharmacokinetic model for controlled release oxyc- odone 显示文摘	Mandema JW Kaiko RF Oshlack B	1996	Br J Clin Pharmacol1996，42，6：	1
11	Characterization and val- idation of a pharmacokinetic model for controlled-release oxycodone 显示文摘	Mandema JW Kaiko RF Oshlack B	1996	Br l Clin Pharmacol1996，42，6：	1
12	A scaling normalizationmethod for differential expression analysis of RNA-seq da-ta 显示文摘	ROBINSON M D OSHLACK A	2010	Genome Biol2010，11，3：	1
13	A scaling normalization method for differential expression analysis of RNA-seq data 显示文摘	Robinson M D Oshlack A	2010	Genome Biology2010，11，3：	1
14	Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells显示文摘	Yuxia Zhang Jovana Maksimovic Gaetano Naselli Junyan Qian Michael Chopin Marnie E. Blewitt Alicia Oshlack Leonard C. Harrison	2013	Blood2013，，16：	1
15	Transcript length bias in RNA-seq data confounds systems biology显示文摘	Oshlack A Wakefield M J		0，，：	1
16	Characteriza- tion and validation of a pharmacokinetic model for controlled-re- lease oxycodone 显示文摘	MANDEMA JW KAIKO RF OSHLACK B	1996	Br J Clin Pharmacol1996，42，6：	1
17	Characterization and validation of a pharmacokinedc model for controlled-release oxycodone显示文摘	Mandema JW Kaiko RF Oshlack B	1996	Br J Clin Pharmacol1996，42，6：	1
18	Characterization and validation of a pharmacokinetic model for controlled-release oxycodone显示文摘	Madema JW Kaiko RF Oshlack B	1996	Br J Clin Pharmocol1996，42，6：	1
19	Array - based gene discovery with three unrelated subjects shows SCARB2/LIMP -2 deficiency causes myoclonus epilepsy and glomerulosclerosis 显示文摘	Berkovic SF Dibbens LM Oshlack A	2008	Am J Hum Genet2008，82，3：	1
20	The United States experience with oral controlled - release morphine 显示文摘	Kaiko RF Grandy RP Oshlack B	1989	Cancer1989，63，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示